Similar Articles
1741 Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1
1742 Seven-day triple therapy is a better choice for Helicobacter pylori eradication in regions with low antibiotic resistance
1743 Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma
1744 Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection
1745 Quinolone-based first, second and third-line therapies for Helicobacter pylori
1746 Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanism
1747 Bile acid receptors and nonalcoholic fatty liver disease
1748 Treating morbid obesity in cirrhosis: A quest of holy grail
1749 Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis
1750 Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA